FDA Approved: OJJAARA — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved OJJAARA (momelotinib) from GlaxoSmithKline in an original application for the treatment of myelofibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• OJJAARA (MOMELOTINIB)

Snippet

ORIG AP for OJJAARA (MOMELOTINIB)